Evaluation of a novel Scheimpflug-based non-contact tonometer in healthy subjects and patients with ocular hypertension and glaucoma.
نویسندگان
چکیده
BACKGROUND To evaluate the agreement of intraocular pressure (IOP) and central corneal thickness (CCT) measurements obtained with the non-contact tonometer Corvis Scheimpflug Technology (Corvis ST, OCULUS, Wetzlar, Germany) versus Goldmann applanation tonometry (GAT) and ultrasound-based corneal pachymetry (US-CCT). METHODS Eye healthy participants, patients with ocular hypertension (OHT) and patients with open-angle glaucoma were included in this prospective study. In each participant, GAT, US-CCT and measurements with Corvis ST were obtained (Corvis-IOP and Corvis-CCT). Accuracy and repeatability were tested by correlation and regression analyses, Bland-Altman plots and assessment of intraclass correlation coefficients. RESULTS A consecutive series of 188 right study eyes of 188 participants (142 eyes with glaucoma, 10 eyes with OHT and 36 control eyes) were included in this prospective study. The mean GAT of all included was 14.5±4.8 mm Hg compared with mean Corvis-IOP of 15.4±5.6 mm Hg (Spearman's r=0.75, p<0.0001). Mean US-CCT was 544.56±40.0 µm compared with Corvis-CCT of 545.2±46.5 µm (Pearson's r=0.78, p<0.0001). Bland-Altman plots of all included eyes as well as subgroup analyses revealed good agreement of the IOP and CCT measurement techniques. High intraclass correlation coefficient values in 17 patients with repeated measurements revealed very good repeatability (0.942 and 0.937 for Corvis-IOP and Corvis-CCT, respectively). Corvis-IOP but not GAT showed a trend of dependence on CCT. CONCLUSIONS Obtaining CCT and measuring IOP with the Corvis ST reveals very good repeatability and good accuracy in healthy subjects and patients with OHT and glaucoma when compared with standardised US pachymetry or GAT.
منابع مشابه
Rho Kinase Inhibitors as a Novel Treatment for Glaucoma and Ocular Hypertension
In an elegant example of bench-to-bedside research, a hypothesis that cells in the outflow pathway actively regulate conventional outflow resistance was proposed in the 1990s and systematically pursued, exposing novel cellular and molecular mechanisms of intraocular pressure (IOP) regulation. The critical discovery that pharmacologic manipulation of the cytoskeleton of outflow pathway cells dec...
متن کاملبررسی ارتباط بین ضخامت مرکز قرنیه و میزان فشار داخل چشمی اندازه گیری شده با تونومتر گلدمن
To determine the effect of central corneal thickness (CCT) on measured intraocular pressure (IOP) and evaluating the relationship between them in each of the groups of patients including: Normal subjects, ocular hypertension patients and patients with primary open angle glucoma (POAG). Correlation between intraocular pressure (Measured by Goldman applanation tonometer) and central corneal thick...
متن کاملOcular pulse amplitude in patients with open angle glaucoma, normal tension glaucoma, and ocular hypertension
Background/aim: Intraocular pressure (IOP) is not a fixed constant value but rather has pulsatile components associated with cardiac action. The SmartLens dynamic observing tonometer (odc, Ophthalmic Development Company AG, Zurich, Switzerland) can measure and record simultaneously IOP and ocular pulse amplitude (OPA). It was the aim of this study to evaluate OPA in patients with primary open a...
متن کاملSCIENTIFIC CORRESPONDENCE Ocular pulse amplitude in patients with open angle glaucoma, normal tension glaucoma, and ocular hypertension
Background/aim: Intraocular pressure (IOP) is not a fixed constant value but rather has pulsatile components associated with cardiac action. The SmartLens dynamic observing tonometer (odc, Ophthalmic Development Company AG, Zurich, Switzerland) can measure and record simultaneously IOP and ocular pulse amplitude (OPA). It was the aim of this study to evaluate OPA in patients with primary open a...
متن کاملEvaluation of the Effect of Latanoprostene Bunod Ophthalmic Solution, 0.024% in Lowering Intraocular Pressure over 24 h in Healthy Japanese Subjects
INTRODUCTION Latanoprostene bunod is a novel nitric oxide (NO)-donating prostaglandin F2α receptor agonist in clinical development for the reduction of intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. We evaluated the effect of latanoprostene bunod 0.024% instilled once daily (QD) on lowering IOP over a 24-h period in healthy Japanese subjects following 14...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- The British journal of ophthalmology
دوره 97 11 شماره
صفحات -
تاریخ انتشار 2013